Geron Flight from hESC Research is 'Powerful Blow'
The news about Geron's abrupt departure from hESC research is rippling around the world this morning, casting a pall over the entire field.
The Financial Times of London, in a story by Andrew Jack, said,
"Geron, the pioneering stem cell therapy company, has dealt a powerful blow to one of the most hyped areas of medicinal research by withdrawing entirel…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.